Affordable Access

Hormone replacement therapy after cancers.

Authors
Type
Published Article
Journal
Current Opinion in Oncology
1040-8746
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
17
Issue
5
Pages
493–499
Identifiers
PMID: 16093802
Source
Medline
License
Unknown

Abstract

There seems to be little if any risk in giving hormone replacement therapy to women who have had breast or endometrial cancer. There are no data to suggest that hormone replacement therapy is contraindicated in women who have been treated for cervical or ovarian cancer.

Statistics

Seen <100 times